Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease

Παρόμοια τεκμήρια

• Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
  ανά: Ray, Balmiki, κ.ά.
  Έκδοση: (2020)
• Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons
  ανά: Bailey, Jason A., κ.ά.
  Έκδοση: (2011)
• Are pulmonary fibrosis and Alzheimer's disease linked? Shared dysregulation of two miRNA species and downstream pathways accompany both disorders
  ανά: Lahiri, Debomoy K., κ.ά.
  Έκδοση: (2017)
• Memantine treatment decreases levels of secreted Alzheimer’s amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells
  ανά: Ray, Balmiki, κ.ά.
  Έκδοση: (2009)
• Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue
  ανά: Ray, Balmiki, κ.ά.
  Έκδοση: (2016)